Close Menu
    What's Hot

    Denmark July CPI rises 1.3% as annual inflation slows

    August 11, 2026

    Gold extends three-day rally before US inflation reports

    August 11, 2026

    Extreme heat could cut EU economic growth in 2026

    August 11, 2026
    Hebrew StandardHebrew Standard
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Hebrew StandardHebrew Standard
    Home » Cellebrite Announces Upcoming Investor Events on June 10, 2026
    PR Newswire

    Cellebrite Announces Upcoming Investor Events on June 10, 2026

    June 5, 2026
    Facebook Twitter Pinterest LinkedIn Telegram Tumblr Email

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that the Company plans to participate in two upcoming investor events on June 10, 2026.

    (PRNewsfoto/Cellebrite)

    Date:

    June 10, 2026

    Event:

    Cellebrite AI Technology Talk

    Overview:

    A deep dive into AI at Cellebrite – from vulnerability research to internal use and
    the introduction of Genesis, the Company’s new agentic AI platform for
    investigations

    Presentation Time:

    9:00 a.m. ET

    Format:

    Webcast

    Event URL:

    https://investors.cellebrite.com/events/event-details/cellebrite-technology-talk

    Webcast URL:

    https://jp-morgan-tech-talk-with-cellebrite-management-oe-live-jun-2026.open-exchange.net/ 

    Moderated by:

    Brian Essex, CFA, executive director, J.P. Morgan

    Cellebrite executives:

    Shiven Ramji, president, products & technology

    Christopher Wade, chief technology officer

    Evyatar Ramot, head of AI Innovation

    Date:

    June 10, 2026

    Conference:

    Mizuho Technology Conference 2026

    Presentation Time:

    11:15 a.m. ET

    Format:

    Fireside Chat

    Event URL:

    https://investors.cellebrite.com/events/event-details/mizuho-technology-conference-2026

    Webcast URL:

    https://kvgo.com/mizuho/cellebrite-di-ltd-june-2026

    Cellebrite executives:

    David Barter, chief financial officer

    Andrew Kramer, vice president, investor relations & treasury

    About Cellebrite 
    Cellebrite’s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency, and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com and find us on social media @Cellebrite.

    Investors Relations
    Andrew Kramer
    Vice President, Investor Relations & Treasury
    investors@cellebrite.com
    +1 973.206.7760

    Media 
    Victor Cooper
    Sr. Director of Corporate Communications + Content Operations
    Victor.cooper@cellebrite.com
    +1 404.804.5910

    Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cellebrite-announces-upcoming-investor-events-on-june-10-2026-302792142.html

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Nitinotes Announces Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center Clinical Site Activation in the EASE™ IDE Trial

    August 11, 2026

    Neurolief Expands Veterans’ Access to Prescription Neuromodulation for Depression and Migraine Through New VA Contract

    August 11, 2026

    WEKA and Andromeda Partner to Power AI Workloads at Global Scale

    July 30, 2026

    Continuity Biosciences Appoints Vicky Papoutsis to Board of Directors

    July 30, 2026

    Nitinotes Announces First Study Procedures at Orlando Health in the EASE™ IDE Trial

    July 28, 2026

    WEKA Unveils WEKApod 3: The World’s Densest AI Storage and Memory System for Agentic Workloads

    July 21, 2026
    Latest News

    Denmark July CPI rises 1.3% as annual inflation slows

    August 11, 2026

    Gold extends three-day rally before US inflation reports

    August 11, 2026

    Extreme heat could cut EU economic growth in 2026

    August 11, 2026

    DR Congo Ebola outbreak passes 1,900 deaths

    August 11, 2026

    Typhoon Dolphin moves inland after mass evacuations in China

    August 11, 2026

    Spain launches border checks for travelers from Italy

    August 10, 2026

    Record heat pushes up food prices across South Korea

    August 10, 2026

    Magnitude 5.0 earthquake shakes Alaska near Atka

    August 10, 2026
    © 2026 Hebrew Standard | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.